Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 69 Fallopian Tube Neoplasms 18 Endometrial Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Breast Neoplasms 7 Neoplasms 5 Pancreatic Neoplasms 3 Cystadenocarcinoma, Serous 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Prostatic Neoplasms 2 Ovarian Diseases 2 Neoplasm Metastasis 2 Gonadal Disorders 2 Genital Neoplasms, Female 2 Genital Diseases, Female 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2 Carcinoma 2 Adnexal Diseases 2 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Sarcoma 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Recurrence 1 Prostatic Diseases 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Platinum-resistant Ovarian Cancer 1

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × niraparib × Gynecologic × Clear all

NCT07059676 2025-07-11

LIBINI-1

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡